Jennifer Panlilio is a program officer at the Diagnostics Accelerator at the Alzheimer’s Drug Discovery Foundation (ADDF), where she focuses on peripheral fluid biomarkers. In this role, she manages portfolio diligence and oversees program operations. Prior to joining ADDF, she served as a health science policy analyst at the National Institutes of Health (NIH), leading strategic communications for the agency’s internal neuroscience research program. She earned her PhD through the Joint Program between the Massachusetts Institute of Technology and Woods Hole Oceanographic Institution, where her research examined how environmental contaminants affect neural development.